Drug recall D-1145-2022
Product
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.
Reason for recall
Lack of assurance of sterility
Lots and codes
Lot #: HAC1951A, Exp 06/2023
Recall details
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
- Quantity
- 4625 syringes
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 6, 2022
- Terminated
- August 14, 2023
Related products
- Medroxyprogesterone acetate – drug information
- NDC 62756-091 Medroxyprogesterone Acetate · Medroxyprogesterone Acetate 150 mg/mL · Sun Pharmaceutical Industries, Inc.